These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 15903251)

  • 1. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
    Dong H; Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
    Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
    Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
    Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
    Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: part I. Cell density, viability, and cell-cycle distribution.
    Dalm MC; Cuijten SM; van Grunsven WM; Tramper J; Martens DE
    Biotechnol Bioeng; 2004 Dec; 88(5):547-57. PubMed ID: 15459904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial and total cell retention in a filtration-based homogeneous perfusion reactor.
    Banik GG; Heath CA
    Biotechnol Prog; 1995; 11(5):584-8. PubMed ID: 8546841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Step-up/step-down perfusion approach for increased mAb 520C9 production by a hybridoma cell line.
    Sen S; Roychoudhury PK
    Biotechnol Lett; 2013 Feb; 35(2):153-63. PubMed ID: 23086570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
    Kim BJ; Chang HN; Oh DJ
    Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
    Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
    Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable hybridoma cultivation in a pilot-scale acoustic perfusion system: long-term process performance and effect of recirculation rate.
    Dalm MC; Jansen M; Keijzer TM; van Grunsven WM; Oudshoorn A; Tramper J; Martens DE
    Biotechnol Bioeng; 2005 Sep; 91(7):894-900. PubMed ID: 15959892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
    Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A perfusion system for high productivity of monoclonal antibody by hybridoma cells in a CelliGen bioreactor.
    Chen Y
    Chin J Biotechnol; 1992; 8(3):179-86. PubMed ID: 1295598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant antibody production by perfusion cultures of rCHO cells in a depth filter perfusion system.
    Lee JC; Chang HN; Oh DJ
    Biotechnol Prog; 2005; 21(1):134-9. PubMed ID: 15903250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
    Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
    Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of three-dimensional culturing in a fibrous matrix on cell cycle, apoptosis, and MAb production by hybridoma cells.
    Luo J; Yang ST
    Biotechnol Prog; 2004; 20(1):306-15. PubMed ID: 14763857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of monoclonal antibodies in culture.
    Reuveny S; Velez D; Riske F; MacMillan JD; Miller L
    Dev Biol Stand; 1985; 60():185-97. PubMed ID: 3930316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity.
    Tey BT; Al-Rubeai M
    Apoptosis; 2004 Nov; 9(6):843-52. PubMed ID: 15505426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.